Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 207.00
Bid: 206.00
Ask: 206.50
Change: 1.50 (0.73%)
Spread: 0.50 (0.243%)
Open: 202.50
High: 207.00
Low: 202.50
Prev. Close: 205.50
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement and Interim Management Statement

13 May 2010 07:00

13 May 2010

Tullett Prebon plc

AGM Statement and Interim Management Statement

Tullett Prebon plc (the "Company") is today issuing its Interim Management Statement in relation to the period from 1 January 2010. This statement will be delivered to those attending the Annual General Meeting today.

Business Update

The performance of the business continues to be robust. Financial markets have remained unsettled and activity in the markets has remained at the level experienced during the second half of 2009, although this is lower than during the exceptionally volatile markets experienced in the first half of 2009. The level of activity has, however, picked up in recent days, reflecting increased market volatility.

The underlying revenue run rate in the first four months of the year at constant exchange rates has been 3% lower than a year ago. In addition the net effect of the broker defections in the second half of last year in North America following a raid on the business by BGC, has been to reduce revenue by 6%. Revenue in the four months to April was £312m, 12% lower than reported for the equivalent period last year, including the adverse impact of currency movements on the translation of our non-UK operations.

Action has been taken to strengthen the management and organisation of our North American business, including replacing a number of staff. The benefit from the actions that have been taken to mitigate the impact of the broker defections will increase during the year as the rebuilding programme continues and the new brokers hired build up to their full run rate of revenue. The underlying revenue run rate in comparison with the prior year is also expected to continue to improve, particularly in the second half.

On 18 March 2010 Judgment was handed down in the legal action that the Company had taken in London against BGC, two of BGC's senior directors and ten former Company brokers, in response to a raid by BGC in early 2009 on the London business. The Judge held that there was an unlawful conspiracy between BGC and its two senior directors to poach the Company's employees and that the Company was and is entitled to injunctions against BGC and the former brokers as well as financial remedies. It may take around 12 months for the financial remedies due to the Company to be determined. The Judge dismissed BGC's counter-claim against the Company. At a Directions hearing on 30 April 2010 permission for BGC to appeal was refused on 20 out of 22 grounds. In particular permission to appeal against the finding of conspiracy was refused.

Legal action continues to be pursued against BGC and former employees in the United States, and against former employees in Hong Kong who have unlawfully terminated their employment with the Company in order to join BGC.

The Company's financial position remains strong.

Enquiries:

Nigel Szembel, Head of Communications, Tullett Prebon plc

Mobile: +44 7802 362088

vendor
Date   Source Headline
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20244:45 pmRNSResult of 2024 AGM
15th May 20247:00 amRNSTrading Statement
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20243:00 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:00 amRNS2023 Annual Report and Notice of 2024 AGM
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.